Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06370624
Other study ID # 2022/03OCT/360
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 17, 2023
Est. completion date October 1, 2025

Study information

Verified date April 2024
Source Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a prospective, observational, single-center study to assess the correlation between rs-fMRI measures and clinical measures of standard MRI, NIRS, EEG and clinical scores. The target population was neonates with HIE referred to MRI after hypothermia treatment, which was initiated within 6 hours of birth, continued for 72 hours and followed by a slow rewarming period of 6-12 hours. A one-year clinical and imaging follow-up is planned. As the aim of the present study is to assess the predictiveness of the outcome one year after the HIE event, no follow-up is planned.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 30
Est. completion date October 1, 2025
Est. primary completion date September 15, 2025
Accepts healthy volunteers No
Gender All
Age group 1 Hour to 14 Months
Eligibility Inclusion Criteria: Newborns at 36 weeks gestation or more, with HIE treated with therapeutic hypothermia will be prospectively included. Exclusion Criteria: - Lack of parental consent - Congenital anomalies that make hypothermia treatment not indicated - Coagulopathy with active bleeding

Study Design


Intervention

Diagnostic Test:
MRI-scan
IRM-scan at rest under neonatologist monitoring.

Locations

Country Name City State
Belgium Cliniques Universitaires Saint Luc Brussels

Sponsors (1)

Lead Sponsor Collaborator
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary quantifying cerebrovascular reactivity (CVR) by resting-state functional MRI (r-fMRI) in infants with moderate to severe hypoxic-ischaemic encephalopathy (HIE) Correlation between RCV mapping EEG/MRI at birth, directly after hypothermia and at 1 year of baby's life
See also
  Status Clinical Trial Phase
Terminated NCT01192776 - Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE) N/A
Completed NCT01862250 - Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia Phase 1/Phase 2
Completed NCT01793129 - Preemie Hypothermia for Neonatal Encephalopathy N/A
Recruiting NCT03162653 - Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome Phase 3
Completed NCT00614744 - Late Hypothermia for Hypoxic-Ischemic Encephalopathy N/A